AngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2020 Update
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. Its products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. The company sells its products through direct sales force in the US and through a network of distributors outside the US. AngioDynamics is headquartered in New York, the US.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company AngioDynamics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
TABLE OF CONTENTS
AngioDynamics Inc Company Overview
AngioDynamics Inc Company Snapshot
AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
AngioDynamics Inc Pipeline Analysis Overview
Business Description
AngioDynamics Inc - Key Facts
AngioDynamics Inc - Major Products and Services
AngioDynamics Inc Pipeline Products by Development Stage
AngioDynamics Inc Ongoing Clinical Trials by Trial Status
AngioDynamics Inc Pipeline Products Overview
AngioVac - Generation 4
AngioVac - Generation 4 Product Overview
AngioVac Low Profile Catheter
AngioVac Low Profile Catheter Product Overview
Automated Fluid Management System
Automated Fluid Management System Product Overview
BioFlo PICC Line Extension
BioFlo PICC Line Extension Product Overview
BioFlo Portline Line Extension
BioFlo Portline Line Extension Product Overview
Coronary Angio Catheter
Coronary Angio Catheter Product Overview
FireFly Tip Location
FireFly Tip Location Product Overview
Inflation Device
Inflation Device Product Overview
Mechanical Thrombectomy Device
Mechanical Thrombectomy Device Product Overview
Multi-Purpose Mechanical Aspirator
Multi-Purpose Mechanical Aspirator Product Overview
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma Product Overview
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma Clinical Trial
Nanoknife System - Bladder Cancer
Nanoknife System - Bladder Cancer Product Overview
Nanoknife System - Bladder Cancer Clinical Trial
NanoKnife System - Cervical Cancer
NanoKnife System - Cervical Cancer Product Overview
NanoKnife System - Cervical Cancer Clinical Trial
NanoKnife System - Head And Neck Cancer
NanoKnife System - Head And Neck Cancer Product Overview
NanoKnife System - Head And Neck Cancer Clinical Trial
NanoKnife System - Lung Cancer
NanoKnife System - Lung Cancer Product Overview
NanoKnife System - Lung Cancer Clinical Trial
Nanoknife System - Metastatic Lymph Nodes
Nanoknife System - Metastatic Lymph Nodes Product Overview
Nanoknife System - Metastatic Lymph Nodes Clinical Trial
NanoKnife System - Prostate Cancer
NanoKnife System - Prostate Cancer Product Overview
NanoKnife System - Prostate Cancer Clinical Trial
NanoKnife System - Rectal Cancer
NanoKnife System - Rectal Cancer Product Overview
NanoKnife System - Rectal Cancer Clinical Trial
Nanoknife System - Renal Pelvis Urothelial Neoplasms
Nanoknife System - Renal Pelvis Urothelial Neoplasms Product Overview
Nanoknife System - Renal Pelvis Urothelial Neoplasms Clinical Trial
NanoKnife System - Stage III Pancreatic Cancer
NanoKnife System - Stage III Pancreatic Cancer Product Overview
NanoKnife System - Stage III Pancreatic Cancer Clinical Trial
Nanoknife System - Stomach Neoplasm
Nanoknife System - Stomach Neoplasm Product Overview
Nanoknife System - Stomach Neoplasm Clinical Trial
Next Gen Tumescent Delivery Device
Next Gen Tumescent Delivery Device Product Overview
Next Generation BioFlo PICC
Next Generation BioFlo PICC Product Overview
Next Generation BioFlo Port
Next Generation BioFlo Port Product Overview
Next Generation Dialysis Device
Next Generation Dialysis Device Product Overview
Next Generation Laser
Next Generation Laser Product Overview
Next Generation Radio Frequency Ablation System
Next Generation Radio Frequency Ablation System Product Overview
Non-Thermal Vein Ablation Device
Non-Thermal Vein Ablation Device Product Overview
Peripheral Vascular Drainage Line Extension
Peripheral Vascular Drainage Line Extension Product Overview
RadiaDyne Endorectal Balloon Device
RadiaDyne Endorectal Balloon Device Product Overview
Smart Port - Dual
Smart Port - Dual Product Overview
Ultrasound-Assisted Thrombectomy System
Ultrasound-Assisted Thrombectomy System Product Overview
AngioDynamics Inc - Key Competitors
AngioDynamics Inc - Key Employees
AngioDynamics Inc - Key Employee Biographies
AngioDynamics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
AngioDynamics Inc, Recent Developments
Feb 06, 2020: AngioDynamics appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
Jan 17, 2020: AngioDynamics begins study on Auryon atherectomy system
Jan 07, 2020: AngioDynamics reports fiscal 2020 second quarter financial results
Oct 22, 2019: AngioDynamics announces departure of CFO and appointment of interim CFO
Oct 03, 2019: AngioDynamics reports fiscal 2020 first quarter financial results
Sep 09, 2019: AngioDynamics awarded Premiers nationally outsourced implantable infusion port agreement
Jul 31, 2019: AngioDynamics announces appointment of former Johnson & Johnson executive Karen Licitra to its Board of Directors
Jul 10, 2019: AngioDynamics reports fiscal 2019 fourth quarter and full-year financial results
Jun 05, 2019: Medline completes AngioDynamics NAMIC portfolio acquisition
May 22, 2019: AngioDynamics receives FDA approval to initiate pilot study for the use of NanoKnife to treat prostate cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Tables
AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
AngioDynamics Inc Pipeline Products by Equipment Type
AngioDynamics Inc Pipeline Products by Indication
AngioDynamics Inc Ongoing Clinical Trials by Trial Status
AngioDynamics Inc, Key Facts
AngioDynamics Inc, Major Products and Services
AngioDynamics Inc Number of Pipeline Products by Development Stage
AngioDynamics Inc Pipeline Products Summary by Development Stage
AngioDynamics Inc Ongoing Clinical Trials by Trial Status
AngioDynamics Inc Ongoing Clinical Trials Summary
AngioVac - Generation 4 - Product Status
AngioVac - Generation 4 - Product Description
AngioVac Low Profile Catheter - Product Status
AngioVac Low Profile Catheter - Product Description
Automated Fluid Management System - Product Status
Automated Fluid Management System - Product Description
BioFlo PICC Line Extension - Product Status
BioFlo PICC Line Extension - Product Description
BioFlo Portline Line Extension - Product Status
BioFlo Portline Line Extension - Product Description
Coronary Angio Catheter - Product Status
Coronary Angio Catheter - Product Description
FireFly Tip Location - Product Status
FireFly Tip Location - Product Description
Inflation Device - Product Status
Inflation Device - Product Description
Mechanical Thrombectomy Device - Product Status
Mechanical Thrombectomy Device - Product Description
Multi-Purpose Mechanical Aspirator - Product Status
Multi-Purpose Mechanical Aspirator - Product Description
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Status
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Description
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation (IRE) for the Treatment of Unresectable Hepatic Carcinoma Close to the Gallbladder
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Colorectal Metastatic Liver Disease: Efficacy of Irreversible Electroporation (IRE) - A Phase II Clinical Trial: COLDFIRE-2 Study
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Comparison Percutaneous Cryosurgery and Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Hepatic Carcinoma in Poor Liver Function: Safety and Efficacy of Irreversible Electroporation (IRE)
NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Irreversible Electroporation (IRE) for Unresectable Portal Venous Tumor Emboli: Phase I and Phase II Clinical Trial
Nanoknife System - Bladder Cancer - Product Status
Nanoknife System - Bladder Cancer - Product Description
Nanoknife System - Bladder Cancer - Irreversible Electroporation (IRE) for Unresectable Urinary Bladder Neoplasms: Phase I and Phase II Clinical Trial
NanoKnife System - Cervical Cancer - Product Status
NanoKnife System - Cervical Cancer - Product Description
NanoKnife System - Cervical Cancer - Irreversible Electroporation (IRE) for Unresectable Uterine Cervical Neoplasms: Phase I and Phase II Clinical Trial
NanoKnife System - Head And Neck Cancer - Product Status
NanoKnife System - Head And Neck Cancer - Product Description
NanoKnife System - Head And Neck Cancer - Irreversible Electroporation (IRE) for Unresectable Head and Neck Neoplasms: Phase I and Phase II Clinical Trial
NanoKnife System - Lung Cancer - Product Status
NanoKnife System - Lung Cancer - Product Description
NanoKnife System - Lung Cancer - Irreversible Electroporation (IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency: Phase I and Phase II Clinical Trial
Nanoknife System - Metastatic Lymph Nodes - Product Status
Nanoknife System - Metastatic Lymph Nodes - Product Description
Nanoknife System - Metastatic Lymph Nodes - Irreversible Electroporation (IRE) for Unresectable Lymph Node Metastases: Phase I and Phase II Clinical Trial
NanoKnife System - Prostate Cancer - Product Status
NanoKnife System - Prostate Cancer - Product Description
NanoKnife System - Prostate Cancer - A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in a Low and Intermediate Risk Patient Population
NanoKnife System - Prostate Cancer - Examination of Focal Therapies - MRI-Fusion, HIFU, NanoKnife and Cryotherapy
NanoKnife System - Prostate Cancer - Focal Irreversible Electroporation as Salvage Treatment in Radio-recurrent Prostate Cancer: A Prospective Multicenter Pilot Study
NanoKnife System - Prostate Cancer - Multi-center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer
NanoKnife System - Prostate Cancer - Registry of Irreversible Electroporation for the Ablation of Prostate Cancer with Use of Nanoknife Device; A Multi-center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety
NanoKnife System - Rectal Cancer - Product Status
NanoKnife System - Rectal Cancer - Product Description
NanoKnife System - Rectal Cancer - Irreversible Electroporation (IRE) for Unresectable Rectal Neoplasms: Phase I and Phase II Clinical Trial
Nanoknife System - Renal Pelvis Urothelial Neoplasms - Product Status
Nanoknife System - Renal Pelvis Urothelial Neoplasms - Product Description
Nanoknife System - Renal Pelvis Urothelial Neoplasms - Irreversible Electroporation (IRE) for Unresectable Renal Pelvic and Ureteral Neoplasms: Phase I and Phase II Clinical Trial
NanoKnife System - Stage III Pancreatic Cancer - Product Status
NanoKnife System - Stage III Pancreatic Cancer - Product Description
NanoKnife System - Stage III Pancreatic Cancer - A Pilot Study of Irreversible Electroporation for the Treatment of Upfront Resectable Pancreatic Cancer in the Head of the Pancreas
NanoKnife System - Stage III Pancreatic Cancer - A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
NanoKnife System - Stage III Pancreatic Cancer - Ablation of Unresectable Locally Advanced Pancreatic Cancer with Nanoknife Irreversible Electroporation (IRE) System: Response and Tolerability
NanoKnife System - Stage III Pancreatic Cancer - An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined with Radiotherapy and Chemotherapy in Patients with Locally Advanced Pancreatic Cancer
NanoKnife System - Stage III Pancreatic Cancer - Assessing Optimal Treatment Settings for the Ablation of Locally Advanced Pancreatic Cancer with CT-guided Percutaneous Irreversible Electroporation (ANTILOPE): A Randomized Feasibility Study
NanoKnife System - Stage III Pancreatic Cancer - Crossatlantic Randomized Controlled Trial Comparing Outcome in Survival after Systemic Plus Focal Therapy for Inoperable Pancreatic Carcinoma: Radiotherapy Versus Irreversible Electroporation: CROSSFIRE Trial
NanoKnife System - Stage III Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study
NanoKnife System - Stage III Pancreatic Cancer - Interest of Irreversible Electroporation in the Treatment of Pancreatic Adenocarcinoma
NanoKnife System - Stage III Pancreatic Cancer - IRE: Anti-tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer
NanoKnife System - Stage III Pancreatic Cancer - Irreversible Electroporation for Locally Advanced Pancreatic Ductal Adenocarcinoma (LEAP TRIAL): A Phase I/II Prospective Trial
NanoKnife System - Stage III Pancreatic Cancer - Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
NanoKnife System - Stage III Pancreatic Cancer - Systemic Therapy with a Loco-regional Treatment in Patients with Locally Advanced Pancreatic Cancer: The SMART Study
Nanoknife System - Stomach Neoplasm - Product Status
Nanoknife System - Stomach Neoplasm - Product Description
Nanoknife System - Stomach Neoplasm - Irreversible Electroporation (IRE) for Unresectable Stmoach Neoplasms: Phase I and Phase II Clinical Trial
Next Gen Tumescent Delivery Device - Product Status
Next Gen Tumescent Delivery Device - Product Description
Next Generation BioFlo PICC - Product Status
Next Generation BioFlo PICC - Product Description
Next Generation BioFlo Port - Product Status
Next Generation BioFlo Port - Product Description
Next Generation Dialysis Device - Product Status
Next Generation Dialysis Device - Product Description
Next Generation Laser - Product Status
Next Generation Laser - Product Description
Next Generation Radio Frequency Ablation System - Product Status
Next Generation Radio Frequency Ablation System - Product Description
Non-Thermal Vein Ablation Device - Product Status 6
Non-Thermal Vein Ablation Device - Product Description 6
Peripheral Vascular Drainage Line Extension - Product Status
Peripheral Vascular Drainage Line Extension - Product Description
RadiaDyne Endorectal Balloon Device - Product Status
RadiaDyne Endorectal Balloon Device - Product Description
Smart Port - Dual - Product Status
Smart Port - Dual - Product Description
Ultrasound-Assisted Thrombectomy System - Product Status
Ultrasound-Assisted Thrombectomy System - Product Description
AngioDynamics Inc, Key Employees
AngioDynamics Inc, Key Employee Biographies
AngioDynamics Inc, Other Locations
AngioDynamics Inc, Subsidiaries
Glossary
List Of Figures
AngioDynamics Inc Pipeline Products by Equipment Type
AngioDynamics Inc Pipeline Products by Development Stage
AngioDynamics Inc Ongoing Clinical Trials by Trial Status
RELATED REPORTS
AngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2021 Update
AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic
View ReportAngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2019 Update
AngioDynamics Inc (AngioDynamics) provides minimally invasive medical, surgical and diagnostic devices. Its product portfolio encompasses peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories,
View ReportAngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2021 Update
AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic
View ReportAngioDynamics Inc (ANGO) - Product Pipeline Analysis, 2019 Update
AngioDynamics Inc (AngioDynamics) provides minimally invasive medical, surgical and diagnostic devices. Its product portfolio encompasses peripheral vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories,
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
